Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov 1;12(1):e2020079.
doi: 10.4084/MJHID.2020.079. eCollection 2020.

The Diagnostic Pitfalls of Mucormycosis

Affiliations
Case Reports

The Diagnostic Pitfalls of Mucormycosis

Margherita Mauro et al. Mediterr J Hematol Infect Dis. .

Abstract

Background: Invasive mucormycosis is a very aggressive fungal disease among immunocompromised pediatric patients caused by saprophytic fungi that belong to the order of the Mucorales.

Case report: We describe a case of of Lichtheimia corymbifera infection in a 15-year-old child with B-cell-Non-Hodgkin Lymphoma (B-NHL) involving lung, kidney and thyroid that initially was diagnosed as probable aspergillosis delaying the effective therapy for mucormycosis.

Conclusions: This case showed that also the intensive chemotherapy for B-NHL may represent a risk factor for mucormycosis infection. Liposomal amphotericin B and surgery remain the key tools for the successful treatment of this aggressive disease.

Keywords: Fungal infection; Mucormycosis; Pediatric non Hodgkin lymphoma.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no conflict of Interest.

Figures

Figure 1
Figure 1
CT lung scan showing the extensive consolidation (57 x 61 mm) at the lower lobe of the left lung associated with pleural effusion.
Figure 2
Figure 2
CT lung scan showing the slight increment of the left lung consolidation (53 x 77 mm) appearing as an area of pulmonary opacity surrounded by normal parenchyma.
Figure 3
Figure 3
Illustration shows the microscopic examination of Lichtheimia corymbifera.

Similar articles

Cited by

References

    1. Bassetti M, Bouza E. Invasive mould infections in the ICU setting: complexities and solutions. J Antimicrob Chemother. 2017;72(Suppl 1):i39–i47. doi: 10.1093/jac/dkx032. - DOI - PubMed
    1. Francis JR, Villanueva P, Bryant P, Blyth CC. Mucormycosis in children: review and recommendations for management. J Pediatric Infect Dis Soc. 2017;00:1–6. - PubMed
    1. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):23–34. doi: 10.1093/cid/cir866. - DOI - PubMed
    1. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RI, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53. doi: 10.1086/432579. - DOI - PubMed
    1. Zaoutis TE, Roilides E, Chiou CC, Buchanan WL, Knudsen TA, Sarkisova TA, et al. Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J. 2007;26:723–7. doi: 10.1097/INF.0b013e318062115c. - DOI - PubMed

Publication types